Total n (%) | |||
---|---|---|---|
to Normoglycemia | to IFG | to Diabetes | |
Study period | |||
0–3 | |||
from normoglycemia | 551 (73,47%) | 167 (22,27%) | 32 (4,27%) |
from IFG | 172 (49,86%) | 121 (35,07%) | 52 (15,07%) |
0–6 | |||
from normoglycemia | 563 (75,07%) | 128 (17,07%) | 59 (7,87%) |
from IFG | 162 (46,96%) | 101 (29,28%) | 82 (23,77%) |
3–6 | |||
from normoglycemia | 614 (84,92%) | 91 (12,59%) | 18 (2,49%) |
from IFG | 111 (38,54%) | 138 (47,92%) | 39 (13,54%) |
Women | |||
0–3 | |||
from normoglycemia | 377 (78,54%) | 87 (18,12%) | 16 (3,33%) |
from IFG | 130 (57,52%) | 70 (30,97%) | 26 (11,50%) |
0–6 | |||
from normoglycemia | 379 (78,96%) | 70 (14,58%) | 31 (6,46%) |
from IFG | 115 (50,88%) | 71 (31,42%) | 40 (17,69%) |
3–6 | |||
from normoglycemia | 429 (84,62%) | 65 (12,82%) | 13 (2,56%) |
from IFG | 65 (41,40%) | 76 (48,41%) | 16 (10,19%) |
Men | |||
0–3 | |||
from normoglycemia | 174 (64,44%) | 80 (29,63%) | 16 (5,93%) |
from IFG | 42 (35,29%) | 51 (42,86%) | 26 (21,85%) |
0–6 | |||
from normoglycemia | 184 (68,15%) | 58 (21,48%) | 28 (10,37%) |
from IFG | 47 (39,50%) | 30 (25,21%) | 42 (35,29%) |
3–6 | |||
from normoglycemia | 185 (85,65%) | 26 (12,04%) | 5 (2,32%) |
from IFG | 46 (35,11%) | 62 (47,33%) | 23 (17,56%) |
Urban | |||
0–3 | |||
from normoglycemia | 438 (81,56%) | 78 (14,53%) | 21 (3,91%) |
from IFG | 119 (63,98%) | 43 (23,12%) | 24 (12,90%) |
0–6 | |||
from normoglycemia | 423 (78,77%) | 76 (14,15%) | 38 (7,08%) |
from IFG | 99 (53,23%) | 48 (25,81%) | 39 (20,97%) |
3–6 | |||
from normoglycemia | 480 (86,18%) | 66 (11,85%) | 11 (1,97%) |
from IFG | 42 (34,71%) | 58 (47,93%) | 21 (17,35%) |
Rural | |||
0–3 | |||
from normoglycemia | 113 (53,05%) | 89 (41,78%) | 11 (5,16%) |
from IFG | 53 (33,33%) | 78 (49,06%) | 28 (17,61%) |
0–6 | |||
from normoglycemia | 140 (65,73%) | 52 (24,41%) | 21 (9,86%) |
from IFG | 63 (39,62%) | 53 (33,33%) | 43 (27,04%) |
3–6 | |||
from normoglycemia | 134 (80,72%) | 25 (15,06%) | 7 (4,22%) |
from IFG | 69 (41,32%) | 80 (47,90%) | 18 (10,78%) |